| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SERES THERAPEUTICS INC | 12,682,876 | 368,438,000 | 62.99% | ||
| 2 | EDITAS MEDICINE INCORPORATED | 4,955,316 | 120,910,000 | 20.67% | ||
| 3 | SYROS PHARMACEUTICALS INC | 4,806,656 | 87,241,000 | 14.92% | ||
| 4 | T2 BIOSYSTEMS INC | 741,755 | 5,852,000 | 1.00% | ||
| 5 | ELEVEN BIOTHERAPEUTICS INC | 1,466,417 | 2,464,000 | 0.42% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001012975-16-001432, filed 2016.08.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
